{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T06:19:58Z","timestamp":1709965198288},"reference-count":25,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1620\/tjem.240.25","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T18:05:36Z","timestamp":1472148336000},"page":"25-30","source":"Crossref","is-referenced-by-count":5,"title":["Common Polymorphisms in&lt;i&gt; GSTA1&lt;\/i&gt;, &lt;i&gt;GSTM1&lt;\/i&gt; and &lt;i&gt;GSTT1 &lt;\/i&gt;Are Associated with Susceptibility to Urinary Bladder Cancer in Individuals from Balkan Endemic Nephropathy Areas of Serbia"],"prefix":"10.1620","volume":"240","author":[{"given":"Marija","family":"Matic","sequence":"first","affiliation":[{"name":"Institute of Medical and Clinical Biochemistry"},{"name":"Faculty of Medicine, University of Belgrade"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Dragicevic","sequence":"additional","affiliation":[{"name":"Clinic of Urology, Clinical Center of Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Pekmezovic","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology"},{"name":"Faculty of Medicine, University of Belgrade"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Suvakov","sequence":"additional","affiliation":[{"name":"Institute of Medical and Clinical Biochemistry"},{"name":"Faculty of Medicine, University of Belgrade"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Savic-Radojevic","sequence":"additional","affiliation":[{"name":"Institute of Medical and Clinical Biochemistry"},{"name":"Faculty of Medicine, University of Belgrade"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Pljesa-Ercegovac","sequence":"additional","affiliation":[{"name":"Institute of Medical and Clinical Biochemistry"},{"name":"Faculty of Medicine, University of Belgrade"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejan","family":"Dragicevic","sequence":"additional","affiliation":[{"name":"Clinic of Urology, Clinical Center of Serbia"},{"name":"Faculty of Medicine, University of Belgrade"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Smiljic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Simic","sequence":"additional","affiliation":[{"name":"Institute of Medical and Clinical Biochemistry"},{"name":"Faculty of Medicine, University of Belgrade"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Andonova, I.E., Sarueva, R.B., Horvath, A.D., Simeonov, V.A., Dimitrov, P.S., Petropoulos, E.A. &amp; Ganev, V.S. (2004) Balkan endemic nephropathy and genetic variants of glutathione S-transferases. <i>J<\/i>. <i>Nephrol.<\/i>, 17, 390-398."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Batuman, V. (2006) Fifty years of Balkan endemic nephropathy: daunting questions, elusive answers. <i>Kidney Int.<\/i>, 69, 644-646.","DOI":"10.1038\/sj.ki.5000231"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Castegnaro, M., Canadas, D., Vrabcheva, T., Petkova-Bocharova, T., Chernozemsky, I.N. &amp; Pfohl-Leszkowicz, A. (2006) Balkan endemic nephropathy: role of ochratoxins A through biomarkers. <i>Mol. Nutr. Food Res.<\/i>, 50, 519-529.","DOI":"10.1002\/mnfr.200500182"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Coles, F.B. &amp; Kadlubar, F.F. (2005) Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. In <i>Glutathione Transferases and Gamma-Glutamyl Transpeptidases, Methods Enzymology<\/i>, edited by Helmut, S. &amp; Lester, P. Elsevier Academic Press, London, pp 9-42.","DOI":"10.1016\/S0076-6879(05)01002-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cosyns, J. (2003) Aristolochic acid and \u2018Chinese herbs nephropathy\u2019: a review of the evidence to date. <i>Drug Saf.<\/i>, 26, 33-48.","DOI":"10.2165\/00002018-200326010-00004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Di Pietro, G., Magno, L.A. &amp; Rios-Santos, F. (2010) Glutathione S-transferases: an overview in cancer research. <i>Expert Opin. Drug Metab. Toxicol.<\/i>, 6, 153-170.","DOI":"10.1517\/17425250903427980"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Eaton, D.L. &amp; Bammler, T.K. (1999) Concise review of the glutathione S-transferases and their significance to toxicology. <i>Toxicol. Sci.<\/i>, 49, 156-164.","DOI":"10.1093\/toxsci\/49.2.156"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Eslami, S. &amp; Sahebkar, A. (2014) Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies. <i>Curr. Hypertens. Rep.<\/i>, 16, 432.","DOI":"10.1007\/s11906-014-0432-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Hayes, J.D., Flanagan, J.U. &amp; Jowsey, I.R. (2005) Glutathione transferases. <i>Annu. Rev. Pharmacol. Toxicol.<\/i>, 45, 51-88.","DOI":"10.1146\/annurev.pharmtox.45.120403.095857"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Honaker, M.T., Acchione, M., Zhang, W., Mannervik, B. &amp; Atkins, W.M. (2013) Enzymatic detoxication, conformational selection, and the role of molten globule active sites. <i>J. Biol. Chem.<\/i>, 288, 18599-18611.","DOI":"10.1074\/jbc.M112.445767"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Johns, L.E. &amp; Houlston, R.S. (2000) Glutathione S-transferase <i>\u03bc<\/i>1 (GSTM1) status and bladder cancer risk: a meta-analysis. <i>Mutagenesis<\/i>, 15, 399-404.","DOI":"10.1093\/mutage\/15.5.399"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kim, S.K., Kang, S.W., Chung, J.H., Park, H.J., Cho, K.B. &amp; Park, M.S. (2015) Genetic polymorphisms of glutathione-related enzymes (GSTM1, GSTT1, and GSTP1) and schizophrenia risk: a meta-analysis. <i>Int. J. Mol. Sci.<\/i>, 16, 19602-19611.","DOI":"10.3390\/ijms160819602"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Landi, S. (2000) Mammalian class <i>\u03b8<\/i> GST and differential susceptibility to carcinogens: a review. <i>Mutat. Res.<\/i>, 463, 247-283.","DOI":"10.1016\/S1383-5742(00)00050-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Lebrun, S., Golka, K., Schulze, H. &amp; F\u00f6llmann, W. (2006) Glutathione S-transferase polymorphisms and ochratoxin A toxicity in primary human urothelial cells. <i>Toxicology<\/i>, 224, 81-90.","DOI":"10.1016\/j.tox.2006.04.034"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Matic, M.G., Coric, V.M., Savic-Radojevic, A.R., Bulat, P.V., Pljesa-Ercegovac, M.S., Dragicevic, D.S., Djukic, T.I., Simic, T.P. &amp; Pekmezovic, T.D. (2014) Does occupational exposure to solvents and pesticides in association with glutathione S-transferase A1, M1, P1, and T1 polymorphisms increase the risk of bladder cancer? The Belgrade case-control study. <i>PLoS One<\/i>, 9, e99448.","DOI":"10.1371\/journal.pone.0099448"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Moore, L.E., Boffetta, P., Karami, S., Brennan, P., Stewart, P.S., Hung, R., Zaridze, D., Matveev, V., Janout, V., Kollarova, H., Bencko, V., Navratilova, M., Szeszenia-Dabrowska, N., Mates, D., Gromiec, J., et al. (2010) Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. <i>Cancer Res.<\/i>, 70, 6527-6536.","DOI":"10.1158\/0008-5472.CAN-09-4167"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Morel, F., Rauch, C., Coles, B., Le Ferrec, E. &amp; Guillouzo, A. (2002) The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter. <i>Pharmacogenetics<\/i>, 12, 277-286.","DOI":"10.1097\/00008571-200206000-00003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Reljic, Z., Zlatovic, M., Savic-Radojevic, A., Pekmezovic, T., Djukanovic, L., Matic, M., Pljesa-Ercegovac, M., Mimic-Oka, J., Opsenica, D. &amp; Simic, T. (2014) Is increased susceptibility to Balkan endemic nephropathy in carriers of common GSTA1 (*A\/*B) polymorphism linked with the catalytic role of GSTA1in ochratoxin a biotransformation? Serbian case control study and in silico analysis. <i>Toxins <\/i>(<i>Basel<\/i>), 6, 2348-2362.","DOI":"10.3390\/toxins6082348"},{"key":"19","unstructured":"Stefanovic, V. &amp; Cosyns, J. (2004) Balkan Nephropathy. In <i>Oxford textbook of clinical nephrology<\/i>, 3th ed., edited by Davison A.M., Cameron J.S., Grunfeld J.P., Ponticelli, C., Van Ypersele, C., Ritz, E. &amp; Winearrls, C.G. Oxford University, UK, pp. 1095-1102."},{"key":"20","doi-asserted-by":"crossref","unstructured":"Suvakov, S., Damjanovic, T., Stefanovic, A., Pekmezovic, T., Savic-Radojevic, A., Pljesa-Ercegovac, M., Matic, M., Djukic, T., Coric, V., Jakovljevic, J., Ivanisevic, J., Pljesa, S., Jelic-Ivanovic, Z., Mimic-Oka, J., Dimkovic, N., et al. (2013) Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients. <i>Nephrol. Dial. Transplant.<\/i>, 28, 202-212.","DOI":"10.1093\/ndt\/gfs369"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Toncheva, D., Dimitrov, T. &amp; Stojanova, S. (1998) Etiology of Balkan endemic nephropathy: a multifactorial disease? <i>Eur. J. Epidemiol.<\/i>, 14, 389-394.","DOI":"10.1023\/A:1007445120729"},{"key":"22","unstructured":"Toncheva, D.I., Von Ahsen, N., Atanasova, S.Y., Dimitrov, T.G., Armstrong, V.W. &amp; Oellerich, M. (2004) Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. <i>J. Nephrol.<\/i>, 17, 384-389."},{"key":"23","doi-asserted-by":"crossref","unstructured":"Tozlovanu, M., Canadas, D., Pfohl-Leszkowicz, A., Frenette, C., Paugh, R. &amp; Manderville, R. (2012) Glutathione conjugates of ochratoxin A as biomarkers of exposure. <i>Arh. Hig. Rada Toksikol.<\/i>, 63, 417-427.","DOI":"10.2478\/10004-1254-63-2012-2202"},{"key":"24","doi-asserted-by":"crossref","unstructured":"van Bladeren, P. (2000) Glutathione conjugation as a bioactivation reaction. <i>Chem. Biol. Interact.<\/i>, 129, 61-76.","DOI":"10.1016\/S0009-2797(00)00214-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Watson, M.A., Stewart, R.K., Smith, G.B., Massey, T.E. &amp; Bell, D.A. (1998) Human glutathione<i> S-<\/i>transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. <i>Carcinogenesis<\/i>, 19, 275-280.","DOI":"10.1093\/carcin\/19.2.275"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/240\/1\/240_25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:24:17Z","timestamp":1498325057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/240\/1\/240_25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.240.25","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}